NCT03523000: A reported trial by University Hospitals Cleveland Medical Center
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT03523000 |
|---|---|
| Title | A Randomized Double Blind Cross-over Trial of Continuous Intrathecal Infusion for Assessing Patients With Chronic Non-cancer Pain Who Would Benefit From Treatment With Intrathecal Drug Delivery System (IDDS) Implant |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Oct. 18, 2017 |
| Completion date | Oct. 12, 2021 |
| Required reporting date | Oct. 12, 2022, midnight |
| Actual reporting date | Sept. 22, 2022 |
| Date last checked at ClinicalTrials.gov | Dec. 5, 2025 |
| Days late | None |